Cited by 784Pain Management and Placebo EffectPsychosomatic Disorders and Their TreatmentsPharmacovigilance and Adverse Drug Reactions

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Nonspecific Medication Side Effects and the Nocebo Phenomenon

Open access

Barsky, Arthur J.·2002·JAMA

DOI 10.1001/jama.287.5.622

Open this paper in CoChat — free account

Abstract

Patients taking active medications frequently experience adverse, nonspecific side effects that are not a direct result of the specific pharmacological action of the drug. Although this phenomenon is common, distressing, and costly, it is rarely studied and poorly understood. The nocebo phenomenon, in which placebos produce adverse side effects, offers some insight into nonspecific side effect reporting. We performed a focused review of the literature, which identified several factors that appear to be associated with the nocebo phenomenon and/or reporting of nonspecific side effects while taking active medication: the patient's expectations of adverse effects at the outset of treatment; a process of conditioning in which the patient learns from prior experiences to associate medication-taking with somatic symptoms; certain psychological characteristics such as anxiety, depression, and the tendency to somatize; and situational and contextual factors. Physicians and other health care personnel can attempt to ameliorate nonspecific side effects to active medications by identifying in advance those patients most at risk for developing them and by using a collaborative relationship with the patient to explain and help the patient to understand and tolerate these bothersome but nonharmful symptoms.

Integrity signals

Registry

Crossref · 10.1001/jama.287.5.622

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Psychology of Physical Symptoms
Pennebaker, J. W. (1982) · Springer eBooks · doi:10.1007/978-1-4613-8196-9 · Cited by 1,789
Functional Somatic Syndromes
BARSKY, A. J., & Borus, J. F. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00016 · Cited by 964
Self-citation
Drug-related morbidity and mortality. A cost-of-illness model
Johnson, J. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.18.1949 · Cited by 942
The Importance of Placebo Effects in Pain Treatment and Research
Turner, J. A. (1994) · JAMA · doi:10.1001/jama.1994.03510440069036 · Cited by 871
The Role of Medication Noncompliance and Adverse Drug Reactions in Hospitalizations of the Elderly
Col, N. F. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390160093019 · Cited by 765
Drug-Related Hospital Admissions
Einarson, T. R. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700702 · Cited by 520
Adequacy and Duration of Antidepressant Treatment in Primary Care
Katon, W. J., Korff, M. V., Lin, E. H. B., Bush, T. M., & Ormel, J. (1992) · Medical Care · doi:10.1097/00005650-199201000-00007 · Cited by 519
Frequency and cost of serious adverse drug reactions in a department of general medicine
Moore, N. D., Lecointre, D., Noblet, C., & Mabille, M. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00667.x · Cited by 322
Morphine Analgesic Tolerance: Its Situation Specificity Supports a Pavlovian Conditioning Model
Siegel, S. (1976) · Science · doi:10.1126/science.935870 · Cited by 318
Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness
de Craen, A. J. M., Roos, P., de Vries, A. L., & Kleijnen, J. (1996) · BMJ · doi:10.1136/bmj.313.7072.1624 · Cited by 313

Show all 69 references

Sorted by citations

Items 501–600 of 783

Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Hobbs, R. F., Gbinigie, O. A., Shanyinde, M., Yu, L., Harris, V., Dorward, J., Hayward, G., Saville, B. R., Berry, N., Evans, P. H., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106248 · Cited by 8
The association between placebo arm inclusion and adverse event rates in antidepressant randomized controlled trials: An examination of the Nocebo Effect.
Cheung, C. P., Thiyagarajah, M., Abraha, H. Y., Liu, C. S., Lanctôt, K., Kiss, A., Saleem, M., Juda, A., Levitt, A., Schaffer, A., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.004 · Cited by 5
Blinded Oral Challenges with Lactose and Placebo Accurately Diagnose Lactose Intolerance: A Real-Life Study
Rocco, A., Compare, D., Sgamato, C., Martino, A., Simone, L. D., Coccoli, P., Melone, M. L., & Nardone, G. (2021) · Nutrients · doi:10.3390/nu13051653 · Cited by 6
The effect of nocebo explanation and empathy on side-effect expectations of medication use following a fictional GP consultation
Brochowski, V. D., Rubin, G. J., & Webster, R. (2023) · Psychology Health & Medicine · doi:10.1080/13548506.2023.2240072 · Cited by 6
How should uncertainty about upcoming painful procedures be communicated? An experimental study into highly uncertain pain predictions
Myronenko, A., van der Velde, P., Derksen, S. M. J. C., & Peerdeman, K. J. (2023) · Patient Education and Counseling · doi:10.1016/j.pec.2023.108008 · Cited by 6
Health scares: Tracing their nature, growth and spread
MacKrill, K., Witthöft, M., Wessely, S. C., & Petrie, K. J. (2023) · Clinical Psychology in Europe · doi:10.32872/cpe.12209 · Cited by 6
Impacto de la prescripción inducida sobre la relación médico-paciente
Turabián, J. L., & Franco, B. P. (2011) · Revista de Calidad Asistencial · doi:10.1016/j.cali.2010.11.002 · Cited by 6
The effect of rebranding generic medicines on drug efficacy and side effects
MacKrill, K., Kleinstäuber, M., & Petrie, K. J. (2019) · Psychology and Health · doi:10.1080/08870446.2019.1616088 · Cited by 6
Placebo and nocebo effects and their significance in clinical practice
Klarić, M., Mandić, V., Lovrić, S., Ćorić, M. K., & Zovko, N. (2016) · Medicinski Glasnik · doi:10.17392/892-16 · Cited by 6
Management of breast cancer: an overview for therapeutic radiographers
McKittrick, G., Shepherd, P., & Gilleece, T. (2020) · Journal of Radiotherapy in Practice · doi:10.1017/s1460396920000011 · Cited by 6
Managing Erectile Dysfunction in Hypertensive Patients
Handler, J. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00465.x · Cited by 6
Placebo, chronic daily headache, and pain: Ten points to ponder
Lake, A. E. (2006) · Current Pain and Headache Reports · doi:10.1007/s11916-006-0002-6 · Cited by 6
Placebo: Missverständnisse und Vorurteile
Breidert, M., & Hofbauer, K. G. (2010) · Osteopathische Medizin · doi:10.1016/j.ostmed.2010.03.001 · Cited by 6
Keratinocyte Growth Factor: Not Yet Ready for Prime Time
Loprinzi, C. L., & Martenson, J. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.041 · Cited by 6
Nocebo hyperalgesia in patients with fibromyalgia and healthy controls: an experimental investigation of conditioning and extinction processes at baseline and 1-month follow-up
Karacaoglu, M., Peerdeman, K. J., Numans, M. E., Stolk, M. R., Meijer, S., Klinger, R., Veldhuijzen, D. S., van Middendorp, H., & Evers, A. W. M. (2023) · The Journal of Pain · doi:10.1016/j.jpain.2023.05.003 · Cited by 5
Placebo and nocebo effects
Rodrigues, B., Raghuraman, N., Shafir, R., Wang, Y., Watson, L., Cottam, J., Nabi, M., Akintola, T., & Colloca, L. (2025) · Pain · doi:10.1097/j.pain.0000000000003637 · Cited by 5
Comparative effectiveness of different placebos and comparator groups for hand osteoarthritis exploring the impact of contextual factors: A systematic review and meta-analysis of randomised trials
Balsby, I. M., Nielsen, S. M., Christensen, R., Henriksen, M., Dahl, L. U.-M., Berg, J. I., Tarp, S., Kroon, F. P. B., Kloppenburg, M., Zhang, W., et al. (2024) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2024.02.947 · Cited by 5
Individual difference factors that predict evaluations and acceptance of authorized concealment for the reduction of nocebo side effects
Spotts, E. K., Miller, F. G., & Geers, A. L. (2025) · Patient Education and Counseling · doi:10.1016/j.pec.2025.108676 · Cited by 4
Pediatric Consultations: Negative-Word Use and Parent Satisfaction
Gemmiti, M., Hamed, S., Wildhaber, J. H., Pharisa, C., & Klumb, P. L. (2017) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsx061 · Cited by 5
Nocebo effects from negative product information: when information hurts, paying money could heal
Mukherjee, S., & Sahay, A. (2017) · Journal of Consumer Marketing · doi:10.1108/jcm-11-2015-1609 · Cited by 5
The nocebo effect in current practice.
Agnihotri, K. (2020) · PubMed Central · Cited by 5
Placebo and nocebo effects in gambling disorder pharmacological trials: a meta-analysis
Ioannidis, K., Huneke, N. T. M., Solly, J. E., Veronesi, G. F., Tzagarakis, C., Parlatini, V., Westwood, S. J., Giovane, C. D., Baldwin, D. S., Grant, J. E., et al. (2024) · Acta Neuropsychiatrica · doi:10.1017/neu.2024.52 · Cited by 7
Adherence to Pharmacological Smoking Cessation Treatment among Weight-Concerned Women
Raynor, D. A. (2004) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 5
Los pacientes con reacciones adversas a medicamentos presentan una mayor prevalencia de alteraciones emocionales
Gutiérrez-Islas, E., Báez-Montiel, B. B., Turabián, J. L., Bolaños-Maldonado, M., Herrera-Ontañón, J. R., Castro, A. V., & de Castro, F. L. (2012) · Atención Primaria · doi:10.1016/j.aprim.2012.06.010 · Cited by 5
Randomized controlled trials: who fails run-in?
Rees, J. R., Mott, L. A., Barry, E. L., Baron, J. A., Figueiredo, J. C., Robertson, D. J., Bresalier, R. S., & Peacock, J. L. (2016) · Trials · doi:10.1186/s13063-016-1451-9 · Cited by 5
Nocebo and Pain
Amanzio, M., Palermo, S., & Benedetti, F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800538-5.00006-6 · Cited by 5
Nocebo effects by providing informed consent in shared decision making? Not necessarily: a randomized pilot-trial using an open-label placebo approach
Holzhüter, F., & Hamann, J. (2020) · BMC Medical Ethics · doi:10.1186/s12910-020-00541-y · Cited by 5
The Psychological Risks Associated With the Non-medical Switch From Biologics to Biosimilars
Mazzoni, D., Vener, C., Mazzocco, K., Monzani, D., & Pravettoni, G. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.605643 · Cited by 5
Parents are aware of the ototoxic effects of chemotherapy in paediatrics undergoing cancer treatment – Professional versus parental views: A pilot study
Moroe, N., & Hughes, K. (2017) · South African Journal of Communication Disorders · doi:10.4102/sajcd.v64i1.183 · Cited by 5
Neuroimaging in Breast Implant Illness: An fMRI Pilot Study
Miseré, R. M. L., Rutten, S., van den Hurk, J., Colaris, M. J. L., & van der Hulst, R. R. W. J. (2022) · Aesthetic Surgery Journal · doi:10.1093/asj/sjac216 · Cited by 5
A challenge to objective perception in hearing and seeing in counselling psychology
Baron, P. (2015) · Kybernetes · doi:10.1108/k-12-2014-0294 · Cited by 5
Evaluating subjective domains of antipsychotic‐induced adverse effects using heart rate variability
Chang, J. S., Hwang, S. S., Yi, S. H., Kim, Y., Lee, Y. S., Kim, Y. S., & Jung, H. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12226 · Cited by 5
Superstition and Cultural Diversity-Case Study: Isfahan Province, Iran
Rabiei, K., Ghasemi, V., & Arzani, H.-R. (2013) · Mediterranean Journal of Social Sciences · doi:10.5901/mjss.2013.v4n4p73 · Cited by 5
MeViTa: Interactive Visualizations to Help Older Adults with Their Medication Intake Using a Camera-Projector System
Croon, R. D., Cardoso, B., Klerkx, J., Abeele, V. V., & Verbert, K. (2017) · Lecture notes in computer science · doi:10.1007/978-3-319-67744-6_9 · Cited by 5
Contraception for Women with Mental Health Conditions
Hall, K., Steinberg, J., & Marcus, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1233-9_5 · Cited by 4
Modern Personalized Strategies for Breast Cancer Treatment: Bridging Precision Oncology and Psycho-Oncology
Marano, G., Paris, I., Traversi, G., Mazza, O., Pavese, F., D’Angelo, T., Franceschini, G., & Mazza, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15041574 · Cited by 5
Radical citizenship education
Leighton, R. (2022) · Education Citizenship and Social Justice · doi:10.1177/17461979221080604 · Cited by 4
A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease
Rabbitt, L., Keogh, Á., Duane, L., Ferguson, J. P., Hobbins, A. P., McGuire, B. E., Gillespie, P. H., & Egan, L. J. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70086 · Cited by 4
False versus True Statin Intolerance in Patients with Peripheral Artery Disease
Dopheide, J. F., Gillmann, P., Spirk, D., Borozadi, M. K., Adam, L., & Drexel, H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226619 · Cited by 3
Nocebo response intensity and influencing factors in the randomized clinical trials of functional dyspepsia: A systematic review and meta‐analysis
Li, R. J., Zhang, Q., Feng, Y. Q., Pei, Q., He, X. X., Chen, F. P., Wang, D. K., Liu, X. H., Liu, J. S., Hou, X. H., et al. (2023) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13216 · Cited by 4
Aspectos no farmacológicos de las medicaciones
Fernández, J., & Franco, B. P. (2011) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2011.02.010 · Cited by 4
Nocebo Effects: The Dilemma of Disclosing Adverse Events
Colloca, L. (2016) · Research ethics forum · doi:10.1007/978-3-319-28731-7_4 · Cited by 4
Headaches related to latanoprost in open-angle glaucoma
Wang, H., Masselos, K., Kalloniatis, M., & Phu, J. (2021) · Clinical and Experimental Optometry · doi:10.1080/08164622.2021.1878846 · Cited by 4
The Effects of a Blue-Light Filtering Versus Clear Intraocular Implant on Color Appearance
Hammond, B. R., Wooten, B. R., Saint, S. E., & Renzi‐Hammond, L. M. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.12.25 · Cited by 4
Role of Psychosomatic Symptoms in COVID-19 Vaccine Hesitancy
Desai, S. R., Kainth, T., Yadav, G., Kochhar, H., Srinivas, S., Kamil, S. H., & Du, W. (2023) · Vaccines · doi:10.3390/vaccines11050922 · Cited by 4
Chlorogenic acid from sunflower meal regulates the number of immunocompetent cells in animals with toxic liver fibrosis
Bozhkov, A. A., Ganin, V. Y., Akzhyhitov, R. A., Ivanov, E. G., Bilovetska, S. G., Dobrianska, N. I., Novikova, A. V., & Божков, А. И. (2024) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2023.12.007 · Cited by 4
Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherence
Tudor, K., Brooks, J., Howick, J., Fox, R. A., & Aveyard, P. N. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033070 · Cited by 4
Lowering LDL cholesterol in clinical practice: time for change?
Abushamat, L. A., & Ballantyne, C. M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01352-6 · Cited by 4
Regulación, competencia y precios en los mercados de productos sanitarios
López‐Valcárcel, B. G., & Pinilla, J. (2006) · Gaceta Sanitaria · doi:10.1157/13089478 · Cited by 4
Hipertensión arterial, medicación antihipertensiva y disfunción eréctil: una perspectiva basada en la evidencia
Mas, M. (2005) · Revista Internacional de Andrología · doi:10.1016/s1698-031x(05)74684-7 · Cited by 4
Expectations of medicine adverse effects: Perceptual characteristics of tablets and personality background
Köteles, F. G., Tóth, A., & Bárdos, G. (2011) · Clinical and Experimental Medical Journal · doi:10.1556/cemed.5.2011.4.3 · Cited by 4
Review: β blockers increase fatigue and sexual dysfunction but not depression after myocardial infarction
Ko, D. T., Hebert, P. R., & Krumholz, H. M. (2003) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.8.2.40 · Cited by 4
The Placebo Effect in Cardiovascular Disease* *Modified with permission from Frishman WH, Lee W-N, Glasser SP, Bienenfeld L, Chien P, Peterson SJ: The placebo effect in cardiovascular disease. In Frishman WH, Sonnenblick EH, Sica DA, editors: Cardiovascular Pharmacotherapeutics, ed 2, New York, 2003, McGraw Hill. pp 15-25.
Frishman, W. H., Wolff, A. I., Lee, W.-N., Peterson, S. J., & Glasser, S. P. (2005) · Elsevier eBooks · doi:10.1016/b978-0-323-03002-1.50005-7 · Cited by 4
Ensaio clínico quali-quantitativo para avaliar a eficácia e a efetividade do tratamento homeopático individualizado na rinite alérgica perene
Teixeira, M. Z. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2009.tde-10062009-102220 · Cited by 5
Editorial: nocebo effect and switching to biosimilars
Bodegraven, A. A. V., & Boone, N. W. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14509 · Cited by 4
Nocebo effects and psychotropic drug action - an update
Amanzio, M., & Palermo, S. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1722100 · Cited by 4
Patient perspectives on statin intolerance, attribution of the nocebo effect and use of N=1-interventions: a qualitative focus group study
Mijnster, R. J. M., van der Bijl, M. F., Niesthoven, A., Kranenburg, L. W., van der Kuy, P. H. M., Merkelbach, I., Lafeber, M., & van Lennep, J. E. R. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120514 · Cited by 5
Development and Evaluation of Cognitive and Behavioral Strategies to Improve Interventions in Reducing Nocebo Effects
Spotts, E. K., & Geers, A. L. (2025) · Social and Personality Psychology Compass · doi:10.1111/spc3.70094 · Cited by 3
Placebo immune-related adverse events (irAEs): A neglected phenomenon in cancer immunotherapy trials
Zhou, Y., Yu, H., Chen, C., Li, A., Zhang, X., Qiu, H., Du, W., Fu, S., Zhang, L., & Hong, S. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.114203 · Cited by 3
Nocebo Effect of Informed Consent in Interventional Procedures
Ruan, X., & Kaye, A. D. (2015) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000332 · Cited by 3
Nocebo effects on informed consent within medical and psychological settings: A scoping review
Stirling, N. S. J., Bridgland, V. M. E., & Takarangi, M. K. T. (2022) · Ethics & Behavior · doi:10.1080/10508422.2022.2081853 · Cited by 3
Counterconditioning as Treatment to Reduce Nocebo Effects in Persistent Physical Symptoms: Treatment Protocol and Study Design
Meijer, S., van Middendorp, H., Peerdeman, K. J., & Evers, A. W. M. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.806409 · Cited by 3
A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms
Orringer, C. E., Grant, J. K., & Tokgözoğlu, L. S. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01059-x · Cited by 3
Implementation of active injury management (AIM) in youth with acute concussion: A randomized controlled trial
Thomas, D. G., Erpenbach, H., Hickey, R. W., Waltzman, D., Haarbauer-Krupa, J. K., Nelson, L. D., Patterson, C. G., McCrea, M., Collins, M. W., & Kontos, A. P. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106965 · Cited by 3
The Perception among Israeli Gastroenterologists Regarding Treatment of Patients with Biosimilar Medications
Richter, V., Cohen, D. L., Bermont, A., Shalem, T., Broide, E., & Shirin, H. (2023) · Medicina · doi:10.3390/medicina59030523 · Cited by 3
Knowledge and attitudes of German and Swiss community pharmacists towards biologicals and biosimilars – a prospective survey before and after the COVID-19 pandemic
Messner, K., Eickhoff, C., Schulz, M., Allemann, S. S., & Arnet, I. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-10475-x · Cited by 3
Generalization and enhancement of the effects of an active placebo nasal spray on sadness
Wilhelm, M., Fischer, S. M., Rief, W., Fiorio, M., & Barbiani, D. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.045 · Cited by 3
How to Prescribe Information: Health Education Without Health Anxiety and Nocebo Effects
Goli, F., Monajemi, A., Ahmadzadeh, G. H., & Malekian, A. (2016) · Studies in neuroscience, consciousness and spirituality · doi:10.1007/978-3-319-35092-9_7 · Cited by 3
Coronary artery calcium scoring in patients with statin associated muscle symptoms: Prescribing statins for those most likely to benefit
Orringer, C. E., Blaha, M. J., & Stone, N. J. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.09.052 · Cited by 3
Adverse Covid-19 Vaccines Reactions in General Medicine: A Clinical-Epidemiological Case Series Reporting of 73 Patients in Toledo’s (Spain) from February to July 2021
Turabián, J. L. (2021) · Epidemiology International Journal · doi:10.23880/eij-16000204 · Cited by 2
« Effet placebo », des convictions personnelles aux représentations collectives : relecture psychosociale d’un phénomène pharmacodynamique
Balez, R., Couturaud, F., & Touffet, L. (2015) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2015.04.006 · Cited by 4
Biosimilars und der Nocebo-Effekt
Braun, J., Tsiami, S., Buehring, B., KIEFER, D. M., Andreica, I., Baraliakos, X., & Kiltz, U. (2019) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-019-00729-7 · Cited by 3
Impatients
Veysman, B. D. (2008) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2008.00136.x · Cited by 3
Clinical and economic implications of therapeutic switching of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors
Kurdi, A. B., Elliott, R. A., & Chen, L. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000002009 · Cited by 3
Impact of Culture, Education and Socio-Economic Status
Moore, R. S. (2006) · Springer eBooks · doi:10.1007/978-1-4020-3664-4_13 · Cited by 3
L'efficacité thérapeutique : objectivité curative et effet placebo
Boussageon, R. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 3
Placebo response in chronic peripheral neuropathic pain trials: systematic review and meta-analysisPreprint
Duarte, G. S., Mainoli, B., Rodrigues, F. B., Rato, F., Machado, T. L. G. N., Ferreira, J. J., & Costa, J. (2022) · medRxiv · doi:10.1101/2022.02.18.22271196 · Cited by 3
Side effects following administration of open-placebos: A randomized controlled trial
Faasse, K., Gasteiger, C., Borgmann, A., Choi, Y. J., & Petrie, K. J. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.112028 · Cited by 2
Not so great expectations: The role of price and name information in the nocebo effect
Humphreys, K., Lin, M. J., Barnes, K., Hasan, Y., Vignaraja, A., Sarna, K., Geers, A. L., & Faasse, K. (2025) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2025.100630 · Cited by 2
Should we Do more to Improve Oral Contraceptive Continuation?
Castaño, P. M., & White, K. O. (2013) · Women s Health · doi:10.2217/whe.13.10 · Cited by 3
A Proof-of-Concept Visualization to Increase Comprehension of Personal Medication Schemes
Croon, R. D., Klerkx, J., & Duval, E. (2016) · International Conference on Pervasive Computing Technologies for Healthcare · doi:10.4108/eai.16-5-2016.2263320 · Cited by 2
Psychological Symptom Amplification: Are Psychological Symptoms Subject to “Somatization”-Like Processes?
Kontos, N. J., Querques, J., & Freudenreich, O. (2016) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000104 · Cited by 2
Factors affecting medication beliefs among patients newly prescribed oral oncolytic agents
Marshall, V. K., Given, C. W., Given, B. A., Lehto, R. H., & Sikorskii, A. E. (2020) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2020.1855497 · Cited by 2
El efecto placebo y el dolor
Scublinsky, D. (2014) · Revista Argentina de Reumatología · doi:10.47196/rar.v25i1.8 · Cited by 2
N-of-1 Randomized Trials
Mirza, R. D., Vohra, S., Kravitz, R. L., & Guyatt, G. H. (2022) · Springer eBooks · doi:10.1007/978-3-319-52636-2_97 · Cited by 2
Role of pharmaceutical care in therapeutic regimens within the community pharmacy
Filotheidou, A., Theodosis‐Nobelos, P., & Triantis, C. (2023) · Česká a slovenská farmacie · doi:10.5817/csf2023-2-70 · Cited by 2
How familiar are German dermatologists with placebo and nocebo effects and to what extent are these targeted in clinical practice: A survey within the dermatological community
Krefting, F., Hölsken, S., Benson, S., Schedlowski, M., & Sondermann, W. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19258 · Cited by 2
Communication skills-based training about medication switch encounters: pharmacy staff and patients’ experiences
Schackmann, L., Koster, E. S., van Dijk, L., Vervloet, M., & Heringa, M. (2024) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-023-01664-z · Cited by 2
Case Report: Practical approach to unmask unspecific adverse effects under lipid-lowering medication
Büttner, T., Hartmann, G., & Coenen, M. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1604129 · Cited by 2
ARE SOME p EOp LE Hyp ERSENSITIvE TO ELEcTRO- MAGNETIc FIELDS?
Oftedal, G., Rubin, J. H., Hillert, L., & van Rongen, E. (2012) · Cited by 2
Using a Point-of-Dispensing Clinic for Prophylaxis of Meningococcal Disease
Ngo, V. P., Civen, R., Dassey, D. E., Davenport, D., & Mascola, L. (2010) · Biosecurity and Bioterrorism Biodefense Strategy Practice and Science · doi:10.1089/bsp.2009.0026 · Cited by 2
Nocebos and nocebo effects still exist though Hippocrates had recommended that patients would not be harmed
Conti, A. A. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.07.023 · Cited by 2
Neurotechnology and Operational Medicine
Giordano, J. (2014) · CRC Press eBooks · doi:10.1201/b17454-12 · Cited by 2
THE EFFECTS OF DISTRACTION ON SYMPTOMS DURING DRUG PROVOCATION TEST
Çildağ, S. Ş., Şentürk, T., & Sargın, G. (2016) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-688 · Cited by 2
Patient Education in Psychopharmacology and the Risk of Nocebo-Related Treatment Inefficacy and Harm
Andrade, C. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17f12016 · Cited by 2
L’effet Nocebo : particularités et conséquences pour le clinicien
Mouly, S. J., Bergmann, J.-F., & Molimard, M. (2018) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2018.02.021 · Cited by 2
The Dark Side of Body Sensations
Köteles, F. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-63201-4_9 · Cited by 2
The Bright Side of Body Sensations
Köteles, F. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-63201-4_10 · Cited by 2
Kommunikative Herausforderungen im klinischen Alltag
Nestoriuc, Y., & Gerke, L. (2021) · Forum · doi:10.1007/s12312-021-00981-6 · Cited by 2
Placebo Effects and Functional Neurological Disorder: Helpful or Harmful?
Burke, M. J., & Lidstone, S. C. (2022) · Current clinical neurology · doi:10.1007/978-3-030-86495-8_27 · Cited by 2

Authors: Barsky, A. J.
Affiliations: Brigham and Women's Hospital (US)
Corresponding author: Barsky, Arthur J.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2002-02-06
Volume: 287
Issue: 5
Pages: 622
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.287.5.622
OpenAlex: W2030711540
Cited by: 784
References: 69
Citations by year: 2026: 19 · 2025: 36 · 2024: 23 · 2023: 34 · 2022: 54 · 2021: 49 · 2020: 47 · 2019: 53 · 2018: 45 · 2017: 42 · 2016: 39 · 2015: 33 · 2014: 31 · 2013: 27 · 2012: 31
FWCI: 12.69
Type: journal article
Language: en
Open access: green
dash.harvard.edu
Licence: cc-by
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords: nocebo effect, adverse drug reactions, placebo effect, patient expectations, conditioning, anxiety, depression, somatization, patient-physician communication, risk factors
MeSH terms: Attitude to Health, Drug Therapy, Humans, Negativism, Placebos, Risk Factors, Effect Modifier, Epidemiologic, Placebo Effect, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonspecific Medication Side Effects and the Nocebo Phenomenon

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks